Literature DB >> 29478125

Detection of the antiviral activity of epicatechin isolated from Salacia crassifolia (Celastraceae) against Mayaro virus based on protein C homology modelling and virtual screening.

P G Ferreira1, A C Ferraz2, J E Figueiredo1, C F Lima1, V G Rodrigues3,4, A G Taranto2, J M S Ferreira2, G C Brandão5, S A Vieira-Filho5,4, L P Duarte3,4, C L de Brito Magalhães6, J C de Magalhães7,8.   

Abstract

Mayaro fever, caused by Mayaro virus (MAYV) is a sub-lethal disease with symptoms that are easily confused with those of dengue fever, except for polyarthralgia, which may culminate in physical incapacitation. Recently, outbreaks of MAYV have been documented in metropolitan areas, and to date, there is no therapy or vaccine available. Moreover, there is no information regarding the three-dimensional structure of the viral proteins of MAYV, which is important in the search for antivirals. In this work, we constructed a three-dimensional model of protein C of MAYV by homology modelling, and this was employed in a manner similar to that of receptors in virtual screening studies to evaluate 590 molecules as prospective antiviral agents. In vitro bioassays were utilized to confirm the potential antiviral activity of the flavonoid epicatechin isolated from Salacia crassifolia (Celastraceae). The virtual screening showed that six flavonoids were promising ligands for protein C. The bioassays showed potent antiviral action of epicatechin, which protected the cells from almost all of the effects of viral infection. An effective concentration (EC50) of 0.247 μmol/mL was observed with a selectivity index (SI) of 7. The cytotoxicity assay showed that epicatechin has low toxicity, with a 50% cytotoxic concentration (CC50) greater than 1.723 µmol/mL. Epicatechin was found to be twice as potent as the reference antiviral ribavirin. Furthermore, a replication kinetics assay showed a strong inhibitory effect of epicatechin on MAYV growth, with a reduction of at least four logs in virus production. Our results indicate that epicatechin is a promising candidate for further testing as an antiviral agent against Mayaro virus and other alphaviruses.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29478125     DOI: 10.1007/s00705-018-3774-1

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  10 in total

1.  Schinus terebenthifolius Raddi extracts: From sunscreen activity toward protection of the placenta to Zika virus infection, new uses for a well-known medicinal plant.

Authors:  Monika B S Oliveira; Iara B Valentim; Tauane S Rocha; Jaqueline C Santos; Keyla S N Pires; Eloiza L L Tanabe; Karen S C Borbely; Alexandre U Borbely; Marília O F Goulart
Journal:  Ind Crops Prod       Date:  2020-04-28       Impact factor: 5.645

2.  Evaluation of Antiviral Activity of Cyclic Ketones against Mayaro Virus.

Authors:  Luciana S Fernandes; Milene L da Silva; Roberto S Dias; Marcel S da S Lucindo; Ítalo E P da Silva; Cynthia C Silva; Róbson R Teixeira; Sérgio O de Paula
Journal:  Viruses       Date:  2021-10-21       Impact factor: 5.048

Review 3.  Pentacyclic Triterpenoids Isolated from Celastraceae: A Focus in the 13C-NMR Data.

Authors:  Karen Caroline Camargo; Mariana Guerra de Aguilar; Acácio Raphael Aguiar Moraes; Raquel Goes de Castro; Daiane Szczerbowski; Elizabeth Luciana Marinho Miguel; Leila Renan Oliveira; Grasiely Faria Sousa; Diogo Montes Vidal; Lucienir Pains Duarte
Journal:  Molecules       Date:  2022-01-31       Impact factor: 4.411

4.  Evaluation of food effects on the pharmacokinetics of Pelargonium sidoides and Coptis with each bioactive compound berberine and epicatechin after a single oral dose of an expectorant and antitussive agent UI026 in healthy subjects.

Authors:  Yewon Park; WonTae Jung; Eunsol Yang; Kyu-Yeol Nam; Woo-Ri Bong; Jaehee Kim; Kyu Yeon Kim; SeungHwan Lee; Joo-Youn Cho; Jang-Hee Hong; JaeWoo Kim
Journal:  Transl Clin Pharmacol       Date:  2022-03-07

Review 5.  Mayaro Virus: The State-of-the-Art for Antiviral Drug Development.

Authors:  Ana Paula Andreolla; Alessandra Abel Borges; Juliano Bordignon; Claudia Nunes Duarte Dos Santos
Journal:  Viruses       Date:  2022-08-16       Impact factor: 5.818

Review 6.  Mayaro: an emerging viral threat?

Authors:  Yeny Acosta-Ampudia; Diana M Monsalve; Yhojan Rodríguez; Yovana Pacheco; Juan-Manuel Anaya; Carolina Ramírez-Santana
Journal:  Emerg Microbes Infect       Date:  2018-09-26       Impact factor: 7.163

Review 7.  Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors.

Authors:  Changwei Liu; Penghui Li; Zhihao Qu; Wei Xiong; Ailing Liu; Sheng Zhang
Journal:  Molecules       Date:  2019-05-03       Impact factor: 4.411

Review 8.  Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies.

Authors:  Iveta Bernatova; Silvia Liskova
Journal:  Antioxidants (Basel)       Date:  2021-03-16

9.  Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors.

Authors:  Lana Langendries; Rana Abdelnabi; Johan Neyts; Leen Delang
Journal:  Microorganisms       Date:  2021-03-31

10.  Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study.

Authors:  Mohammed Baqur S Al-Shuhaib; Hayder O Hashim; Jafar M B Al-Shuhaib
Journal:  Comput Biol Med       Date:  2021-12-17       Impact factor: 6.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.